Literature DB >> 24925468

Stem cell-derived motor neurons from spinal and bulbar muscular atrophy patients.

Christopher Grunseich1, Kristen Zukosky2, Ilona R Kats3, Laboni Ghosh4, George G Harmison5, Laura C Bott6, Carlo Rinaldi7, Ke-lian Chen8, Guibin Chen9, Manfred Boehm10, Kenneth H Fischbeck11.   

Abstract

Spinal and bulbar muscular atrophy (SBMA, Kennedy's disease) is a motor neuron disease caused by polyglutamine repeat expansion in the androgen receptor. Although degeneration occurs in the spinal cord and muscle, the exact mechanism is not clear. Induced pluripotent stem cells from spinal and bulbar muscular atrophy patients provide a useful model for understanding the disease mechanism and designing effective therapy. Stem cells were generated from six patients and compared to control lines from three healthy individuals. Motor neurons from four patients were differentiated from stem cells and characterized to understand disease-relevant phenotypes. Stem cells created from patient fibroblasts express less androgen receptor than control cells, but show androgen-dependent stabilization and nuclear translocation. The expanded repeat in several stem cell clones was unstable, with either expansion or contraction. Patient stem cell clones produced a similar number of motor neurons compared to controls, with or without androgen treatment. The stem cell-derived motor neurons had immunoreactivity for HB9, Isl1, ChAT, and SMI-32, and those with the largest repeat expansions were found to have increased acetylated α-tubulin and reduced HDAC6. Reduced HDAC6 was also found in motor neuron cultures from two other patients with shorter repeats. Evaluation of stably transfected mouse cells and SBMA spinal cord showed similar changes in acetylated α-tubulin and HDAC6. Perinuclear lysosomal enrichment, an HDAC6 dependent process, was disrupted in motor neurons from two patients with the longest repeats. SBMA stem cells present new insights into the disease, and the observations of reduced androgen receptor levels, repeat instability, and reduced HDAC6 provide avenues for further investigation of the disease mechanism and development of effective therapy. Published by Elsevier Inc.

Entities:  

Keywords:  Androgen receptor; Induced pluripotent stem cells; Motor neuron disease; Spinal and bulbar muscular atrophy

Mesh:

Substances:

Year:  2014        PMID: 24925468      PMCID: PMC4172362          DOI: 10.1016/j.nbd.2014.05.038

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  33 in total

1.  Men with Kennedy disease have a reduced risk of androgenetic alopecia.

Authors:  R Sinclair; K J Greenland; S van Egmond; C Hoedemaker; A Chapman; J D Zajac
Journal:  Br J Dermatol       Date:  2007-06-26       Impact factor: 9.302

2.  Reversible disruption of dynactin 1-mediated retrograde axonal transport in polyglutamine-induced motor neuron degeneration.

Authors:  Masahisa Katsuno; Hiroaki Adachi; Makoto Minamiyama; Masahiro Waza; Keisuke Tokui; Haruhiko Banno; Keisuke Suzuki; Yu Onoda; Fumiaki Tanaka; Manabu Doyu; Gen Sobue
Journal:  J Neurosci       Date:  2006-11-22       Impact factor: 6.167

3.  Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons.

Authors:  John T Dimos; Kit T Rodolfa; Kathy K Niakan; Laurin M Weisenthal; Hiroshi Mitsumoto; Wendy Chung; Gist F Croft; Genevieve Saphier; Rudy Leibel; Robin Goland; Hynek Wichterle; Christopher E Henderson; Kevin Eggan
Journal:  Science       Date:  2008-07-31       Impact factor: 47.728

4.  Induced pluripotent stem cell generation using a single lentiviral stem cell cassette.

Authors:  Cesar A Sommer; Matthias Stadtfeld; George J Murphy; Konrad Hochedlinger; Darrell N Kotton; Gustavo Mostoslavsky
Journal:  Stem Cells       Date:  2009-03       Impact factor: 6.277

5.  Induced pluripotent stem cells from a spinal muscular atrophy patient.

Authors:  Allison D Ebert; Junying Yu; Ferrill F Rose; Virginia B Mattis; Christian L Lorson; James A Thomson; Clive N Svendsen
Journal:  Nature       Date:  2008-12-21       Impact factor: 49.962

6.  HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS.

Authors:  Udai Bhan Pandey; Zhiping Nie; Yakup Batlevi; Brett A McCray; Gillian P Ritson; Natalia B Nedelsky; Stephanie L Schwartz; Nicholas A DiProspero; Melanie A Knight; Oren Schuldiner; Ranjani Padmanabhan; Marc Hild; Deborah L Berry; Dan Garza; Charlotte C Hubbert; Tso-Pang Yao; Eric H Baehrecke; J Paul Taylor
Journal:  Nature       Date:  2007-06-14       Impact factor: 49.962

7.  HDAC6 regulates androgen receptor hypersensitivity and nuclear localization via modulating Hsp90 acetylation in castration-resistant prostate cancer.

Authors:  Junkui Ai; Yujuan Wang; Javid A Dar; June Liu; Lingqi Liu; Joel B Nelson; Zhou Wang
Journal:  Mol Endocrinol       Date:  2009-10-23

8.  Valosin containing protein associated inclusion body myopathy: abnormal vacuolization, autophagy and cell fusion in myoblasts.

Authors:  Jouni Vesa; Hailing Su; Giles D Watts; Sabine Krause; Maggie C Walter; Barbara Martin; Charles Smith; Douglas C Wallace; Virginia E Kimonis
Journal:  Neuromuscul Disord       Date:  2009-10-13       Impact factor: 4.296

9.  Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy.

Authors:  Isabella Palazzolo; Conor Stack; Lingling Kong; Antonio Musaro; Hiroaki Adachi; Masahisa Katsuno; Gen Sobue; J Paul Taylor; Charlotte J Sumner; Kenneth H Fischbeck; Maria Pennuto
Journal:  Neuron       Date:  2009-08-13       Impact factor: 17.173

10.  Mitochondrial abnormalities in spinal and bulbar muscular atrophy.

Authors:  Srikanth Ranganathan; George G Harmison; Kristin Meyertholen; Maria Pennuto; Barrington G Burnett; Kenneth H Fischbeck
Journal:  Hum Mol Genet       Date:  2008-09-29       Impact factor: 6.150

View more
  30 in total

Review 1.  Clinical Trials in a Dish: The Potential of Pluripotent Stem Cells to Develop Therapies for Neurodegenerative Diseases.

Authors:  Kelly M Haston; Steven Finkbeiner
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-10-28       Impact factor: 13.820

Review 2.  Spinal and Bulbar Muscular Atrophy.

Authors:  Christopher Grunseich; Kenneth H Fischbeck
Journal:  Neurol Clin       Date:  2015-09-08       Impact factor: 3.806

3.  A Human-Based Functional NMJ System for Personalized ALS Modeling and Drug Testing.

Authors:  Xiufang Guo; Virginia Smith; Max Jackson; My Tran; Michael Thomas; Aakash Patel; Eric Lorusso; Siddharth Nimbalkar; Yunqing Cai; Christopher W McAleer; Ying Wang; Christopher J Long; James J Hickman
Journal:  Adv Ther (Weinh)       Date:  2020-08-11

4.  p53 isoforms regulate astrocyte-mediated neuroprotection and neurodegeneration.

Authors:  C Turnquist; I Horikawa; E Foran; E O Major; B Vojtesek; D P Lane; X Lu; B T Harris; C C Harris
Journal:  Cell Death Differ       Date:  2016-04-22       Impact factor: 15.828

Review 5.  Modeling simple repeat expansion diseases with iPSC technology.

Authors:  Edyta Jaworska; Emilia Kozlowska; Pawel M Switonski; Wlodzimierz J Krzyzosiak
Journal:  Cell Mol Life Sci       Date:  2016-06-03       Impact factor: 9.261

6.  Linking epigenetic dysregulation, mitochondrial impairment, and metabolic dysfunction in SBMA motor neurons.

Authors:  Naemeh Pourshafie; Ester Masati; Eric Bunker; Alec R Nickolls; Parisorn Thepmankorn; Kory Johnson; Xia Feng; Tyler Ekins; Christopher Grunseich; Kenneth H Fischbeck
Journal:  JCI Insight       Date:  2020-07-09

7.  Mutation in CPT1C Associated With Pure Autosomal Dominant Spastic Paraplegia.

Authors:  Carlo Rinaldi; Thomas Schmidt; Alan J Situ; Janel O Johnson; Philip R Lee; Ke-Lian Chen; Laura C Bott; Rut Fadó; George H Harmison; Sara Parodi; Christopher Grunseich; Benoît Renvoisé; Leslie G Biesecker; Giuseppe De Michele; Filippo M Santorelli; Alessandro Filla; Giovanni Stevanin; Alexandra Dürr; Alexis Brice; Núria Casals; Bryan J Traynor; Craig Blackstone; Tobias S Ulmer; Kenneth H Fischbeck
Journal:  JAMA Neurol       Date:  2015-05       Impact factor: 18.302

Review 8.  In Vitro and In Vivo Modeling of Spinal and Bulbar Muscular Atrophy.

Authors:  Maria Pennuto; Manuela Basso
Journal:  J Mol Neurosci       Date:  2015-11-27       Impact factor: 3.444

9.  Identification of novel polyglutamine-expanded aggregation species in spinal and bulbar muscular atrophy.

Authors:  Tamar R Berger; Heather L Montie; Pranav Jain; Justin Legleiter; Diane E Merry
Journal:  Brain Res       Date:  2015-10-08       Impact factor: 3.252

Review 10.  Modeling Polyglutamine Expansion Diseases with Induced Pluripotent Stem Cells.

Authors:  Swati Naphade; Kizito-Tshitoko Tshilenge; Lisa M Ellerby
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.